Sana Biotechnology, Inc.SANANASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-14.8%
5Y CAGR+9.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-14.8%/yr
vs +103.1%/yr prior
5Y CAGR
+9.4%/yr
Recent deceleration
Acceleration
-117.9pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$44.30M-30.8%
2024$64.04M-12.6%
2023$73.30M+2.4%
2022$71.56M+42.0%
2021$50.41M+78.3%
2020$28.27M+29.8%
2019$21.78M+417.8%
2018$4.21M-